Mesa Laboratories, Inc.MLABNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank87
3Y CAGR+17.2%
5Y CAGR+1.4%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
+17.2%/yr
vs -5.4%/yr prior
5Y CAGR
+1.4%/yr
Recent acceleration
Acceleration
+22.6pp
Accelerating
Percentile
P87
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $37.69M | -10.9% |
| 2025 | $42.31M | +1.8% |
| 2024 | $41.57M | +77.3% |
| 2023 | $23.44M | -32.6% |
| 2022 | $34.79M | -0.8% |
| 2021 | $35.08M | +40.0% |
| 2020 | $25.06M | -14.4% |
| 2019 | $29.29M | +33.1% |
| 2018 | $22.02M | +671.1% |
| 2017 | $-3.85M | - |